IL6 and metabolic syndrome: The various pathogenic pathways contributing to the development of MetS culminate in a pro-inflammatory state that explains the elevation in various inflammatory markers such as IL-6, C-reactive protein (CRP), and TNFα seen in individuals with MetS [66] (Table 3).